Europeans choosing cannabis over ecstasy

Cannabis consumption increased and ecstasy consumption decreased between March and April 2021, when restrictions caused by the Covid-19 pandemic were in force, reveals a new online survey. “About a third of respondents (32%) reported using more cannabis (herbaceous) and 42% said they used less MDMA/ecstasy,” says the EMCDDA. According to online responses from 48,469 adults in 21 Member States and Switzerland, cannabis was the most used drug, with 93% of users saying they had used it in the last 12 months and with little variation between countries. The survey revealed that a fifth (20%) of the sample reported having consumed LSD in the last year, 16% used new psychoactive substances (NSP) and 13% ketamine. The data refer to a self-selected sample that used at least one illicit drug in the 12 months prior to the survey, explains the EMCDDA.